VISTAGEN THERAPEUTICS INC (VTGN)
US92840H4002 - Common Stock
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology.
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027
Learn the potency of lesser-known stocks and explore their fundamental edge in technology distribution, food retail, and biotechnology.
Vistagen to Present at Stifel 2024 Virtual CNS Days
Vistagen to Present at TD Cowen 44th Annual Health Care Conference
3 Revolutionary Biotech Stocks Poised for 10X Surge
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.
Vistagen Therapeutics files for $350M mixed shelf (NASDAQ:VTGN)
Vistagen Therapeutics files a prospectus for mixed shelf offering of up to $350M, but it's not an offer to sell securities.
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
3 Penny Stocks to Buy for the Next Bull Run: February 2024
As the market pivots in 2024, dive into the dynamic world of penny stocks, revealing the top choices for February's exhilarating bull run.
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.
Vistagen shares move up after Jeffries upgrade (NASDAQ:VTGN)
Vistagen Therapeutics (VTGN) sees a boost in stock after Jefferies raises it to Buy, citing positive results from a Phase 3 study of its social anxiety...
Vistagen shares move up after Jefferies upgrade (NASDAQ:VTGN)
Vistagen Therapeutics (VTGN) sees a boost in stock after Jefferies raises it to Buy, citing positive results from a Phase 3 study of its social anxiety...
Vistagen stock climbs as Stifel starts at Buy (NASDAQ:VTGN)
Vistagen Therapeutics (VTGN) stock rises as Stifel initiates its coverage with a Buy rating, highlighting its anxiety treatment candidate,fasedienol. Read more here.
Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results
Vistagen to Present at Stifel 2023 Healthcare Conference
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!
Vistagen to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
Vistagen prices $100M underwritten offering (NASDAQ:VTGN)
Vistagen Therapeutics (NASDAQ:VTGN) has priced $100M underwritten offering at a combined purchase price of $5.38 per share of common stock, accompanying T1...
Vistagen Announces Pricing of $100 Million Underwritten Offering
The 7 Best Short-Squeeze Stocks to Buy Now: September 2023
Explore the potential of the best short-squeeze stocks to buy now as companies attempt to prove pessimistic traders wrong.